Khosrow Zamani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Khosrow Zamani has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Ali Reza Nateghian
Ali Asghar Clinical Research Development Center (AACRDC), Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publicationFaramarz Masjedian Jezi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, I
1 shared publicationReza Mirnejad
Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
1 shared publicationShabnam Razavi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, I
1 shared publicationShahin Khalilipanah
Student Research Committee, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
1 shared publicationSina Karaji
General practitionerAli Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 30 September 2024
- Published by National Academy of Sciences of Tajikistan in Journal of Current Biomedical Reports
- p. 82-86
Non-caloric artificial sweeteners: A mini-review of current perspectives on health benefits and potential risks
Non-caloric artificial sweeteners (NAS) have gained widespread use in food, beverages, and pharmaceuticals due to their intense sweetness and minimal caloric contribution. Initially introduced as sugar substitutes for weight management and glycemic control, their safety profiles have come under renewed scrutiny. This mini-review summarizes current evidence on the health benefits and potential risks associated with NAS. Clinical trials support their short-term benefits, including modest reductions in body weight, improved glycemic indices, and dental health advantages due to their non-cariogenic properties. Additionally, certain NAS exhibit antimicrobial and antioxidant activities, although these may also disrupt beneficial gut microbiota. Notably, some epidemiological studies have paradoxically linked NAS consumption with weight gain, metabolic disturbances, and cardiovascular risk. Alterations in gut microbiota, neuroendocrine signaling, and taste perception are proposed mechanisms for these effects. Emerging data also raise concerns about carcinogenic and genotoxic potential, particularly for aspartame and acesulfame-K, although findings remain inconsistent across studies. Regulatory agencies maintain acceptable daily intake limits based on toxicological assessments; however, individual susceptibility, cumulative exposure, and long-term outcomes warrant further investigation. Overall, NAS offer useful alternatives to sugar but should be consumed with awareness of potential systemic and microbiome-mediated risks. Ongoing research, particularly well-designed longitudinal human studies, is essential to inform future dietary recommendations and regulatory policies.
- 30 September 2024
- Published by National Academy of Sciences of Tajikistan in Journal of Current Biomedical Reports
- p. 82-86
Open AccessNon-caloric artificial sweeteners: A mini-review of current perspectives on health benefits and potential risks
Non-caloric artificial sweeteners (NAS) have gained widespread use in food, beverages, and pharmaceuticals due to their intense sweetness and minimal caloric contribution. Initially introduced as sugar substitutes for weight management and glycemic control, their safety profiles have come under renewed scrutiny. This mini-review summarizes current evidence on the health benefits and potential risks associated with NAS. Clinical trials support their short-term benefits, including modest reductions in body weight, improved glycemic indices, and dental health advantages due to their non-cariogenic properties. Additionally, certain NAS exhibit antimicrobial and antioxidant activities, although these may also disrupt beneficial gut microbiota. Notably, some epidemiological studies have paradoxically linked NAS consumption with weight gain, metabolic disturbances, and cardiovascular risk. Alterations in gut microbiota, neuroendocrine signaling, and taste perception are proposed mechanisms for these effects. Emerging data also raise concerns about carcinogenic and genotoxic potential, particularly for aspartame and acesulfame-K, although findings remain inconsistent across studies. Regulatory agencies maintain acceptable daily intake limits based on toxicological assessments; however, individual susceptibility, cumulative exposure, and long-term outcomes warrant further investigation. Overall, NAS offer useful alternatives to sugar but should be consumed with awareness of potential systemic and microbiome-mediated risks. Ongoing research, particularly well-designed longitudinal human studies, is essential to inform future dietary recommendations and regulatory policies.
- Open Access
- 1 July 2021
- Published by Elsevier in Asian Journal of Urology
- Vol. 8 (3) , 253-259
A decade of trends in the distribution and antimicrobial susceptibility of prevalent uropathogens among pediatric patients from Tehran, Iran during 2005–2016
- 1 July 2021
- Published by Elsevier in Asian Journal of Urology
- Vol. 8 (3) , 253-259
Open AccessA decade of trends in the distribution and antimicrobial susceptibility of prevalent uropathogens among pediatric patients from Tehran, Iran during 2005–2016
- 1 August 2019
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 65, 29-36
Immunogenic and protective antigens of Brucella as vaccine candidates
- 1 August 2019
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 65, 29-36
Immunogenic and protective antigens of Brucella as vaccine candidates